NIH study indicates drug safe during pregnancy, but infants smaller at first birthday
Bethesda, Maryland–(ENEWSPF)–May 1, 2012. Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network…
